Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Terry's nails, a nail abnormality characterized by a white, frosted appearance with a reddish-brown band at the tip, can indicate underlying health issues like liver cirrhosis, heart failure, diabetes ...

One such condition is known as Terry nails, which might seem like a simple change, but it could be a warning sign of liver ...

A shorter course of prophylactic antibiotics, or even no course at all, appeared to be noninferior to longer courses in ...

Men with cirrhosis have a significantly higher risk for liver-related complications ― particularly hepatocellular carcinoma ― ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague ...

Alcoholic cirrhosis isn’t something that appears overnight. It is the tragic result of long-term alcohol use that scars and weakens the liver, stopping it from doing vital tasks.

Cirrhosis or fibrosis of the liver can occur due to several liver-related diseases and conditions, such as hepatitis, non-alcoholic fatty liver disease, and excessive alcohol consumption.

In patients with hepatocellular carcinoma (HCC), hyponatremia is an independent predictor of increased rates of in-hospital mortality, with a greater impact reported among those with cirrhosis, ...